跳至主要内容
临床试验/JPRN-UMIN000027103
JPRN-UMIN000027103已完成未知

The efficacy of anagliptin in patients with type 2 diabetes mellitus - Study for the efficacy of anagliptin

Juntendo University Urayasu Hospital0 个研究点目标入组 30 人开始时间: 2017年4月30日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Patients with history of hypersensitivity to anagliptin 2.Patients with diabetic ketoacidosis, diabetic coma, or bofore coma, type1 diabetes 3.Severe infection, before and not long after surgery, or patient with severe trauma 4.Women with during pregnancy , nursing, or pregnant likelihood 5.Patients with severe renal dysfunction ,end stage renal disease during dialysis 6.Patients with severe liver dysfunction 7.Inadequte patient judged by doctor

研究者

相似试验